Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.905 USD | +2.19% | -5.04% | -25.19% |
05-13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
05-08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.19% | 201M | |
+14.99% | 74.45B | |
+11.35% | 9.18B | |
+60.16% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.14% | 2.39B | |
-29.25% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- HC Wainwright Cuts KemPharm's Price Target to $10 From $11, Reiterates Buy Rating